Oral phosphate binders in patients with kidney failure

New England Journal of Medicine

Volumn 363, Issue 10, 2010, Pages 989-990

  Feith, Geert W ^a  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; PHOSPHATE BINDING AGENT;

DRUG SAFETY; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL;

EID: 77956294441     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1005274     Document Type: Letter

References (3)

1. Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure. N Engl J Med 2010;362:1312-24.
2. Martin KJ, Gonzales EA, Slatopolsky E. Renal osteodystrophy. In: Brenner BM, Levine SA, eds. Brenner & Rector's The kidney. 7th ed. Philadelphia: Saunders, 2004:2255-304.
3. Jaffe JA, Liftman C, Glickman JD. Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis 2005;46:316-9. (Pubitemid 41040361)